Reuters logo
BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health
2016年11月23日 / 晚上8点22分 / 10 个月前

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

Nov 23 (Reuters) - Navidea Biopharmaceuticals Inc :

* Press release - Navidea signs asset purchase agreement with Cardinal Health

* Navidea will receive $80 million at closing, plus opportunity to earn up to $230 million of contingent consideration

* Says as part of transaction, Cardinal Health will license a portion of acquired intellectual property back to Navidea

* Could earn contingent consideration based on certain milestones through 2026, with $20.1 million of that amount guaranteed over next 3 years Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below